Viewing Study NCT06067295


Ignite Creation Date: 2025-12-24 @ 1:19 PM
Ignite Modification Date: 2026-01-01 @ 2:20 AM
Study NCT ID: NCT06067295
Status: RECRUITING
Last Update Posted: 2025-08-29
First Post: 2023-09-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
Sponsor: University of Southern California
Organization:

Study Overview

Official Title: Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
Status: RECRUITING
Status Verified Date: 2025-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.
Detailed Description: PRIMARY OBJECTIVE:

I. To create an annotated biorepository with prospectively collected blood and urine samples from men with advanced prostate cancer.

OUTLINE: This is an observational study.

Patients undergo blood and urine sample collection, complete surveys, and have their medical records reviewed on study.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
NCI-2023-01434 REGISTRY CTRP (Clinical Trial Reporting Program) View
4P-22-2 OTHER USC / Norris Comprehensive Cancer Center View
P30CA014089 NIH None https://reporter.nih.gov/quic… View